Clover Health Investments closed at $4.69 on Nov 4, up 9.32%, 13.3% below its 52-week closing high. Volume of 7.3M shares was 1.70× its 20-day average (above normal).
Split-adjusted performance: +2.0% over one month, +75.0% over six months, +27.4% over one year.
In the quarter ended Jun 30, 2026, revenue was $743.17M, up 55.6% from a year earlier, with a net margin of 3.8%.
Short interest was 25.9M shares at the Oct 15 settlement, up 13.3% from the prior report (6.2% of float, 5.3 days to cover).